当前位置:首页 - 行情中心 - 梅花生物(600873) - 财务分析 - 现金流量表

梅花生物

(600873)

  

流通市值:293.27亿  总市值:293.27亿
流通股本:28.53亿   总股本:28.53亿

现金流量表

报告期2024-12-312024-09-302024-06-302024-03-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金27,266,900,172.1120,292,035,951.8613,389,911,638.66,458,518,085.2
收到的税费返还590,412,944.2459,602,997.84330,068,330.01154,396,803.23
收到其他与经营活动有关的现金448,943,253.14355,718,519.67302,955,156.78176,776,894.44
经营活动现金流入的平衡项目0000
经营活动现金流入小计28,306,256,369.4521,107,357,469.3714,022,935,125.396,789,691,782.87
购买商品、接受劳务支付的现金20,140,823,405.614,374,153,645.819,916,642,628.25,764,735,765.22
支付给职工以及为职工支付的现金1,968,598,894.61,531,863,315.081,120,919,599.52636,117,807.57
支付的各项税费859,863,649.52606,174,050.88425,300,472.8219,132,820.94
支付其他与经营活动有关的现金710,255,629.26509,454,533.85324,254,301.75200,107,751.08
经营活动现金流出的平衡项目0000
经营活动现金流出小计23,679,541,578.9817,021,645,545.6211,787,117,002.276,820,094,144.81
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额4,626,714,790.474,085,711,923.752,235,818,123.12-30,402,361.94
二、投资活动产生的现金流量:
收回投资收到的现金190,804,566.6812,840,00037,400,00065,493,055.56
取得投资收益收到的现金51,309,310.7124,609,93010,871,635.281,702,976.85
处置固定资产、无形资产和其他长期资产收回的现金净额3,487,009.21,237,1961,065,812638,000
投资活动现金流入的平衡项目0000
投资活动现金流入小计245,600,886.5938,687,12649,337,447.2867,834,032.41
购建固定资产、无形资产和其他长期资产支付的现金2,004,423,105.691,425,811,689.21,048,684,780.6387,432,533.21
投资支付的现金881,089,058.612,342,886,143.381,094,050,606.66171,617,566.67
支付其他与投资活动有关的现金9,047,530--596,645
投资活动现金流出的平衡项目0000
投资活动现金流出小计2,894,559,694.33,768,697,832.582,142,735,387.26559,646,744.88
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-2,648,958,807.71-3,730,010,706.58-2,093,397,939.98-491,812,712.47
三、筹资活动产生的现金流量:
取得借款收到的现金6,297,183,657.374,914,588,328.043,556,386,998.941,835,264,148.92
收到其他与筹资活动有关的现金389,646,523.23287,772,154.46235,856,949.53115,663,953.84
筹资活动现金流入平衡项目0000
筹资活动现金流入小计6,686,830,180.65,202,360,482.53,792,243,948.471,950,928,102.76
偿还债务支付的现金6,411,943,930.695,106,015,680.693,573,136,295.581,616,845,233.46
分配股利、利润或偿付利息支付的现金1,789,239,618.911,268,690,731.641,171,823,531.224,059,899.52
支付其他与筹资活动有关的现金1,223,698,914.69670,263,213.09503,808,378.73149,591,388.61
筹资活动现金流出平衡项目0000
筹资活动现金流出小计9,424,882,464.297,044,969,625.425,248,768,205.511,790,496,521.59
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-2,738,052,283.69-1,842,609,142.92-1,456,524,257.04160,431,581.17
四、汇率变动对现金及现金等价物的影响111,541,460.3471,035,361.9668,078,736.5627,345,563.85
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-648,754,840.59-1,415,872,563.79-1,246,025,337.34-334,437,929.39
加:期初现金及现金等价物余额4,780,614,442.734,780,614,442.734,780,614,442.734,780,614,442.73
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额4,131,859,602.143,364,741,878.943,534,589,105.394,446,176,513.34
补充资料:
净利润2,740,427,215.56-1,473,823,789.92-
资产减值准备6,981,927.26-1,987,907.91-
固定资产和投资性房地产折旧1,275,227,848.29-644,467,539.02-
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧1,275,227,848.29-644,467,539.02-
无形资产摊销45,749,650.73-21,594,903.82-
长期待摊费用摊销36,976,072.81-14,792,568.72-
处置固定资产、无形资产和其他长期资产的损失-29,968.32--1,598,224.17-
固定资产报废损失34,405,586.69-24,205,123.35-
公允价值变动损失-14,826,169.53--1,959,926.94-
财务费用-29,377,272.58--23,730,451.06-
投资损失-30,193,009.09--14,671,408.04-
递延所得税15,127,342.15-23,261,630.32-
其中:递延所得税资产减少14,034,060.21-24,645,983.8-
递延所得税负债增加1,093,281.94--1,384,353.48-
存货的减少202,965,494.39-416,520,802.04-
经营性应收项目的减少306,096,165.23-253,649,805.16-
经营性应付项目的增加37,357,071.5--591,564,282.59-
现金的期末余额4,131,859,602.14-3,534,589,105.39-
减:现金的期初余额4,780,614,442.73-4,780,614,442.73-
公告日期2025-03-182024-10-232024-07-302024-04-09
审计意见(境内)标准无保留意见
TOP↑